UNASSIGNED: @entity0 is one of the most common diseases in the Polish society. In 2015, around 17,000 Polish @entity1 were diagnosed with this type of @entity5 . A comparison of relative survival rates for different European countries shows that the Polish oncological care system is inefficient in terms of @entity0 treatment. @entity1 in Poland have substantially lower chances of surviving the first five years a er being diagnosed than @entity1 in most other European countries. An inspiration, and at the same time the main theme of the paper is assessing the availability of a controversial treatment, i.e. risk-reducing mastectomy, to @entity1 at high risk of @entity0 . The primary goal connected with this issue is an analysis of @entity0 prevention in Poland in light of applicable provisions of law and, in a broader context, availability of oncological services in the scope of @entity0 prevention and treatment in Poland. The following research methods were adopted in the implementation of the above mentioned objectives: non-systematic review of the PubMed medical database, review of literature and other available sources of information, including press releases, conference materials and online sources. Furthermore, relevant acts of law have been selected and analysed, with the use of a pre-specified glossary of key terms. @entity5 are becoming an increasingly big issue. Every year the incidence rates are higher, and in consequence the number of @entity1 receiving @entity5 grows. The current legal regulations governing the availability of @entity5 seem to be insuficient.

Legislation regulating availability of XXXX treatment with particular focus on prophylactic mastectomy.

@entity1 :: ('9606', 'Species') :: ['women', 'patients', 'Women'] @entity5 :: ('MESH:D009369', 'Disease') :: ['Cancers', 'cancer', 'cancer-related benefits'] @entity0 :: ('MESH:D001943', 'Disease') :: ['Breast cancer', 'breast cancer']
@entity0 :: (MESH:D001943,Disease) :: ['breast cancer']
